Ivana Sullivan

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Collaborators (6)

Marie Morfouace

Institut Gustave Roussy

Silvia Vidal

Associate professor

University of Barcelona

Miguel A. Molina‐Vila

Maria J Arranz

Javier De Castro

HEAD OF LUNG CANCER UNIT

La Paz University Hospital

Alessandra Curioni-Fontecedro

Professor of Oncology

University of Fribourg

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ivana Sullivan

Research Interests

Explore related searches

Contact this professor

Articles (13)

Collaborators (6)

Marie Morfouace

Silvia Vidal

Miguel A. Molina‐Vila

Maria J Arranz

Javier De Castro

Alessandra Curioni-Fontecedro

Make your next move.

Ivana Sullivan

Research Interests

Explore related searches

Contact this professor

Articles (13)

Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial

CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer

Clinical and economic impact of the advanced practice nurse in lung cancer patients receiving immunotherapy-based treatments: A quantitative study

ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer

Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors

Potential Role of Circulating PD-L1<sup>+</sup> Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients

EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers

Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1

Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events

Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients

SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)

Collaborators (6)

Marie Morfouace

Silvia Vidal

Miguel A. Molina‐Vila

Maria J Arranz

Javier De Castro

Alessandra Curioni-Fontecedro

Make your next move.